NCT05466552View on ClinicalTrials.gov

The PROTECT-EU Study

RecruitingOBSERVATIONAL
Enrollment

859

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
High-risk PCI
Interventions
PROCEDURE

PCI procedure

During the PCI procedure, use of ECMO/Impella 5.0 is allowed hemodynamic instability (bail- out).

Trial Locations (1)

Unknown

RECRUITING

Ospedale San Raffaele, Milan

Sponsors

Collaborators (1)

Abiomed Inc.
All Listed Sponsors
collaborator

Abiomed Inc.

INDUSTRY

collaborator

University of Padova

OTHER

lead

Fondazione GISE Onlus

OTHER

NCT05466552 - The PROTECT-EU Study | Biotech Hunter | Biotech Hunter